Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 8.74 is 21% above its 5-year average of 7.23, around the middle of its 5-year range (2.57–12.68).
As of the fiscal period ended Tuesday, March 31, 2026. 4.69% above its 12-month average of 8.35.
Reported quarterly quick ratio; no daily interpolation.
QUICK RATIO (ACID-TEST)
8.74
QUICK RATIO (ACID-TEST) AVG TTM
8.35
QUICK RATIO (ACID-TEST) AVG 3Y
9.02
QUICK RATIO (ACID-TEST) AVG 5Y
7.23
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+4.69%
CURRENT VS 3Y AVG
-3.09%
CURRENT VS 5Y AVG
+20.90%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.21
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+622.40%
vs the sector median at left
Market Cap
$22.43B
Quick Ratio (Acid-Test)
6.28
TTM Avg
5.66
3Y Avg
6.29
5Y Avg
6.48
Market Cap
$23.10B
Quick Ratio (Acid-Test)
2.34
TTM Avg
2.22
3Y Avg
2.40
5Y Avg
2.33
Market Cap
$23.51B
Quick Ratio (Acid-Test)
3.25
TTM Avg
2.59
3Y Avg
3.09
5Y Avg
3.29
Market Cap
$24.34B
Quick Ratio (Acid-Test)
1.23
TTM Avg
1.27
3Y Avg
1.23
5Y Avg
1.37
Market Cap
$24.42B
Quick Ratio (Acid-Test)
1.27
TTM Avg
1.39
3Y Avg
1.50
5Y Avg
1.54
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioNTech SE (BNTX) | $22.59B | 8.74 | 8.35 | 9.02 | 7.23 |
| United Therapeutics Corporation (UTHR)vs › | $22.43B | 6.28 | 5.66 | 6.29 | 6.48 |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.10B | 2.34 | 2.22 | 2.40 | 2.33 |
| Incyte Corporation (INCY)vs › | $23.51B | 3.25 | 2.59 | 3.09 | 3.29 |
| Moderna, Inc. (MRNA)vs › | $21.45B | 3.22 | 3.42 | 3.19 | 2.63 |
| STERIS plc (STE)vs › | $20.86B | 1.54 | 1.46 | 1.73 | 1.65 |
| Labcorp Holdings Inc. (LH)vs › | $24.34B | 1.23 | 1.27 | 1.23 | 1.37 |
| Waters Corporation (WAT)vs › | $24.42B | 1.27 | 1.39 | 1.50 | 1.54 |
| Viatris Inc. (VTRS)vs › | $20.08B | 0.74 | 0.86 | 1.00 | 0.90 |
| Quest Diagnostics Incorporated (DGX)vs › | $25.15B | 0.96 | 0.99 | 1.07 | 1.22 |
Quick Ratio
8.74
Excludes inventory
Current Ratio
7.54
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-03-31 | 8.74 |
| 2025-12-31 | 7.49 |
| 2025-09-30 | 7.02 |
| 2025-06-30 | 8.48 |
| 2025-03-31 | 10.02 |
| 2024-12-31 | 7.34 |
| 2024-09-30 | 7.21 |
| 2024-06-30 | 7.40 |
| 2024-03-31 | 11.16 |
| 2023-12-31 | 9.26 |
| 2023-09-30 | 10.14 |
| 2023-06-30 | 10.32 |
| 2023-03-31 | 12.68 |
| 2022-12-31 | 7.28 |
| 2022-09-30 | 5.30 |
| 2022-06-30 | 5.06 |
| 2022-03-31 | 4.93 |
| 2021-12-31 | 4.18 |
| 2021-09-30 | 2.67 |
| 2021-06-30 | 2.57 |
| 2021-03-31 | 2.58 |
| 2020-12-31 | 2.64 |
| 2020-09-30 | 4.02 |
| 2020-06-30 | 2.94 |
| 2020-03-31 | 3.40 |
| 2019-12-31 | 3.97 |
| 2019-09-30 | 3.83 |
| 2019-06-30 | 3.65 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 3.51 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
